Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
FDA Grants IND For Pro-Pharmaceuticals' DAVANAT® To Treat Breast Cancer Patient
http://www.medicalnewstoday.com/articles/119792.php
Pro-Pharmaceuticals, Inc. (Amex: PRW), today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of DAVANAT® in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky.
----------------------------------------------
** CANCER / ONCOLOGY News **
FDA Grants IND For Pro-Pharmaceuticals' DAVANAT® To Treat Breast Cancer Patient
http://www.medicalnewstoday.com/articles/119792.php
Pro-Pharmaceuticals, Inc. (Amex: PRW), today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of DAVANAT® in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky.
Roche's XCELLigence System Offers Dynamic And Label-free Assessing Of Kinase Activity In Living Cells
http://www.medicalnewstoday.com/articles/119791.php
The central role of receptor tyrosine kinases (RTKs) in cellular processes, especially in cancer, has made them an important target for several antibody- and small molecule-based inhibitors specific for various RTKs for the treatment of different tumour entities.
ThermoDox® Liver Cancer Study Phase I Results To Be Presented At ILCA Conference 2008
http://www.medicalnewstoday.com/articles/119790.php
CELSION CORPORATION (NASDAQ: CLSN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox® used in combination with Radio Frequency Ablation (RFA) for the treatment of patients with primary and metastatic liver cancer will be presented at a Poster Presentation session at the International Liver Cancer Association (ILCA) Annual Conference in Chicago, IL, from September 5-7, 2008.
Takeda And Affymax Provide Clinical Development Update For Hematide In Chemotherapy-Induced Anemia
http://www.medicalnewstoday.com/articles/119786.php
Takeda Pharmaceutical Company Limited (TOKYO:4502) and Affymax, Inc. (Nasdaq:AFFY) today announced their agreement to suspend co-development of Hematide™ to treat chemotherapy-induced anemia and to focus all development efforts for Hematide™ on the treatment of chronic kidney disease related anemia.
New Approach To Detect The Early Progression Of Brain Tumors Identified By Barrow Researchers
http://www.medicalnewstoday.com/articles/119707.php
Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect when a patient is failing brain tumor treatment before symptoms appear.
More Than 500,000 Have Cancer In The U.S. But 98% Don't Take Part In Trials
http://www.medicalnewstoday.com/articles/119695.php
Americans are some of the most generous people in the world, whether it's donating time or money, each year more than 60 million of us volunteer* to help others. But that's not always the case when it comes to cancer research.
First International Cancer Film Festival Announces Finalists - Global Line-Up Drawn From Over 250 Countries
http://www.medicalnewstoday.com/articles/119675.php
The finalists for <i>Reel Lives: The Cancer Chronicles,</i> the first ever international documentary film competition on cancer, have been announced in a line-up that includes 2007 Oscar winner <i>Freeheld</i> and many other remarkable films from 16 countries worldwide.
Key To Resistance To Common Cancer Drug Could Be Variation Of Normal Protein
http://www.medicalnewstoday.com/articles/119617.php
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
CDC Urges Pre-Teen Vaccination With New Public Service Announcements
http://www.medicalnewstoday.com/articles/119720.php
The Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases announced that new public service announcements (PSAs) targeting the parents of pre-teens are now available to broadcast organizations.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment